Canada markets closed
  • S&P/TSX

    21,216.15
    +3.76 (+0.02%)
     
  • S&P 500

    4,544.90
    -4.88 (-0.11%)
     
  • DOW

    35,677.02
    +73.94 (+0.21%)
     
  • CAD/USD

    0.8091
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    83.98
    +1.48 (+1.79%)
     
  • BTC-CAD

    76,234.48
    -2,601.24 (-3.30%)
     
  • CMC Crypto 200

    1,453.34
    -49.69 (-3.31%)
     
  • GOLD FUTURES

    1,793.10
    +11.20 (+0.63%)
     
  • RUSSELL 2000

    2,291.27
    -4.92 (-0.21%)
     
  • 10-Yr Bond

    1.6550
    -0.0210 (-1.25%)
     
  • NASDAQ

    15,090.20
    -125.50 (-0.82%)
     
  • VOLATILITY

    15.43
    +0.42 (+2.80%)
     
  • FTSE

    7,204.55
    +14.25 (+0.20%)
     
  • NIKKEI 225

    28,804.85
    +96.27 (+0.34%)
     
  • CAD/EUR

    0.6942
    -0.0010 (-0.14%)
     

The US Oncology Network Announces Trusted Leader Jason Hammonds as New President

·2 min read

Successor will continue The Network’s success in supporting independent oncology practices nationwide

THE WOODLANDS, Texas, September 20, 2021--(BUSINESS WIRE)--The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that it has appointed Jason Hammonds as its new president.

Hammonds has supported The Network for more than 13 years in a range of leadership roles and brings deep industry experience and a stellar track record of accomplishments. Most recently, he served as senior vice president of operations for Texas Oncology, a member of The Network and the largest integrated, community-based oncology practice in the nation.

Previously, Hammonds held roles in both strategy and business development at McKesson, which supports The Network. There, he executed numerous growth activities that added more than 500 physicians to The Network during his tenure.

"I am excited and humbled to lead this phenomenal organization, which is dedicated to empowering physicians and practices to provide the highest quality of care possible to the cancer patients who need them," said Hammonds. "We will stay focused on what is best for the patient by evolving our approach to value-based care, supporting our research capabilities, advancing our operational excellence, and modernizing our technology infrastructure. My goal is to continue supporting The US Oncology Network to the best of our ability so its legacy of exceptional, compassionate care for patients in the community will thrive and move forward in an ever-changing industry."

"Jason has played an instrumental role in helping to grow and evolve The Network for over a decade, and his wide-ranging expertise and achievements make him the perfect fit to lead the organizations," said Kirk Kaminsky, president, U.S. Pharmaceutical, McKesson. "I look forward to working with him as we continue to grow The Network and our oncology ecosystem, aligning with McKesson’s mission of advancing health outcomes for all."

About The US Oncology Network

Every day, The US Oncology Network (The Network) helps approximately 1,400 independent physicians deliver value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides practices with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson Corporation. This collaboration allows the providers in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. The Network is committed to the success of independent practices, everywhere.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210920005099/en/

Contacts

The US Oncology Network
Annabelle Baxter, Public Relations
469.233.3400 annabelle.baxter@mckesson.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting